Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen |
08.05.2025 10:50:37
|
Takeda FY24 Net Profit Down; Lifts Dividend; Sees Higher Profit, But Weak Sales In FY25; Stock Down
(RTTNews) - Takeda Pharmaceutical Company Ltd. (TAK) Thursday reported lower net profit in its fiscal 2024, while profit before tax surged from last year with growth in revenues. Further, the company lifted dividend, and said it projects higher profit for fiscal 2025, but weak core operating profit and revenues.
In pre-market activity on the NYSE, Takeda shares were losing around 3 percent to trade at $14.61.
In the full year, net profit attributable to owners of the company fell 25.1 percent to 107.93 billion yen or $720 million from last year's 144.08 billion yen.
Earnings per share were 67.23 yen or $0.45, lower than prior year's 91.16 yen.
Core net profit was 775.6 billion yen or 491 yen per share, compared to 756.8 billion yen or 484 yen per share last year.
Profit before tax, however, surged 231.7 percent from last year to 175.08 billion yen or $1.17 billion.
Operating profit climbed 60 percent to 342.59 billion yen or $2.29 billion, and core operating profit grew 10.2 percent to 1.16 trillion yen.
Revenue for the year grew 7.5 percent to 4.58 trillion yen or $30.56 billion from last year's 4.26 trillion yen. Revenue grew 2.9 percent at constant currency rates.
Core revenue increased 7.4 percent on a reported basis and 2.8 percent at constant currency rates.
Further, Takeda announced that the annual dividend will be 196 yen per share for fiscal 2024, including year-end dividend of 98 yen per share.
For fiscal 2025, the annual dividend will be 200 yen per share, an year-over-year growth of 2 percent.
For fiscal 2025, the company projects attributable profit of 228.0 billion yen or 144.81 yen per share, a growth of 111.3 percent from the previous year. Core earnings per share would be 485 yen, down 1.2 percent from the prior year.
Operating profit would grow 38.7 percent from last year to 475.0 billion yen, while core operating profit would be down 1.9 percent to 1.14 trillion yen.
Revenue for the year is projected to be down 1.1 percent to 4.53 trillion yen.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
Nachrichten zu Takeda Pharmaceutical Co Ltd. (spons. ADRs)
07.05.25 |
Ausblick: Takeda Pharmaceutical zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | |
23.04.25 |
Erste Schätzungen: Takeda Pharmaceutical zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | |
29.01.25 |
Ausblick: Takeda Pharmaceutical gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) | |
15.01.25 |
Erste Schätzungen: Takeda Pharmaceutical legt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu Takeda Pharmaceutical Co Ltd. (spons. ADRs)
3 Knaller-Aktien 📈im BX Musterportfolio: Trane Techn., Cintas & Deutsche Boerse mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Trane Technologies
✅ Cintas
✅ Deutsche Boerse
Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
US-Börsen mit leichten Gewinnen -- SMI gibt schlussendlich ab -- DAX geht unter 24'000-Punkte-Marke in den Feierabend -- Asiens Börsen letztlich in RotDer heimische sowie der deutsche Aktienmarkt verbuchten im Donnerstagshandel Verluste. Die Wall Street zeigt sich derweil mit Gewinnen. In Fernost gaben die Börsen am Donnerstag nach.
finanzen.net News
Datum | Titel |
---|---|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |